Sangamo Announces ASGCT 2024

Board of Directors

John Markels, Ph.D.

John Markels, Ph.D. has served as a member of Sangamo’s Board of Directors since February 2020. Dr. Markels has over 30 years of leadership experience in the pharmaceutical industry. He currently serves as President of Global Vaccines at Merck, where he leads an integrated team dedicated to discovery and development, supply and access, and global marketing and long-term strategy for the vaccines portfolio. Earlier roles at Merck included President, Latin America, as well as a long career in senior leadership positions in major regions worldwide in manufacturing technology, operations and strategy, business development, alliance management, and supply chain. Dr. Markels currently serves on the board of directors of Arcturus Therapeutics, a publicly traded biotechnology company. Dr. Markels received his Ph.D. in chemical engineering from the University of California, Berkeley and his B.S. in chemical engineering from the University of Delaware.